The Prognostic Value of CXC Chemokine Receptor 2 (CXCR2) in Cancers: A Meta-Analysis

Oncotarget - United States
doi 10.18632/oncotarget.23492
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

CXC Chemokine Receptor 2 (CXCR2)

Science-Business eXchange
2008English

Prognostic Value of microRNA-224 in Various Cancers: A Meta-Analysis

Archives of Medical Research
Medicine
2017English

CXC Chemokine Receptor 6 (CXCR6); Chemokine CXC Motif Ligand 16 (CXCL16)

Science-Business eXchange
2012English

Prognostic Value of MicroRNA-15a in Human Cancers: A Meta-Analysis and Bioinformatics

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Prognostic Value of MICA/B in Cancers: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

CXCR2 Chemokine Receptor Antagonism Enhances DOP Opioid Receptor Function via Allosteric Regulation of the CXCR2–DOP Receptor Heterodimer

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2008English

CXC Chemokine Receptor 4 (CXCR4; NPY3R); Chemokine CXC Motif Ligand 12 (CXCL12; SDF-1); CXCR7

Science-Business eXchange
2012English

The Chemokine Receptor CXCR2 Contributes to Murine Adipocyte Development

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2018English

Prognostic Significance of TAZ Expression in Various Cancers: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy